Declaration of conflict of interest. I have nothing to disclose.
|
|
- Douglas French
- 5 years ago
- Views:
Transcription
1 Declaration of conflict of interest I have nothing to disclose.
2 Left Bundle branch block in HF: DO GENETICS MATTER? Silvia Giuliana Priori Cardiovascular Genetics, Langone Medical Center, New York University School of Medicine, New York, USA and Molecular Cardiology, IRCCS Fondazione Maugeri Dept of Cardiology, University of Pavia. Italy
3 QRS AND HEART FAILURE Nearly 5 million Americans suffer from heart failure (HF), and more than die annually for the disease. Intraventricular conduction delay caused by asymmetrical contraction is present in 1/3 of HF patients and it may be an independent risk factor for death. LBB decreases regional loading, contractile work, myocardial blood flow, and oxygen consumption in the early-activated anterior myocardium, whereas these parameters are increased in the late-activated lateral LV. CRT improves contractile synchrony, systolic function and rehomogenizes regional workload.
4 Genetics and LBBB in HF The question whether genetic abnormalities are part of the interaction between conduction delay/dyssynchrony and increased mortality is an important one. Two aspects need to be discussed: 1) Role of the genome: is there a genetic predisposition to develop LBBB? 2) Changes in the trascriptome: Do genetic factors account for the effect of LBBB on prognosis?
5 Is there a genetic predisposition to develop LBBB? Data from inherited diseases.
6 Inherited Cardiac Conduction Diseases (1) Progressive cardiac conduction defect (PCCD) is a frequent disease attributed to degeneration and fibrosis of the His bundle. Over the past years, gene defects have been identified demonstrating that PCCD could be a genetic disease as mutations in SCN5A, SCN1B and TRPM4 have been identified as the causal genes of inherited progressive cardiac conduction disease.
7 Inherited Cardiac Conduction Diseases (2) In a recent French study in families with CCD, progressive hemiblocks and RBBB were the most frequent conduction defects (44% and 33%, respectively). whereas LBBB was unfrequent (5%). Genetic predisposition to CCD seems to cause predominantly RBBB. Gourraud J B et al. Heart 2012;98:
8 Inherited DCM + CCD caused by LAMIN A/C mutations The cardiac phenotype associated with LMNA mutations is characterized by atrial fibrillation, conduction disturbances, ventricular arrhythmias, and dilated cardiomyopathy In a meta-analysis of 299 carriers of a lamin A/C mutation (van Berlo et al J Mol Med 2005), 18% of patients less than 10 years of age had evidence of delayed intracardiac conduction. In patients over 30 years of age, 92% had conduction system disease, with 44% requiring pacemaker placement At variant with the genes implicated in CCD, Lamin A/C ia linked to LBBB.
9 Heritability of human electrocardiogram Heritability represents a relevant component of the human electrocardiogram In the general population, ECG intervals duration have on average 25-40% of their variability attributable to genetic factors. Single SNPs are usually associated with small effect. This implies the evaluation of large cohorts of patients in order to detect significant signals and differentiate them from noise. Genetics: Meta-analysis identifies variants in 22 loci associated with QRS duration. Osório J.Nat Rev Cardiol Feb;8(2):
10 Pleiotropic associations of ECG variables Sotoodehnia N et al Nature Genetics 2010
11 GWAS of QRS complex duration in 40,407 healthy subjects Sotoodehnia N et al Nature Genetics 2010
12 SNPs that modulates the ECG predict SCD? ECG parameters like QRS duration and QTc duration influence the risk of SCD. Solid evidence from GWAS studies has shown that QRS and QT duration are modulated by common genetic variants CAN WE ASSUME THAT SCD IS INFLUENCED BY SNPs THAT MODULATE THE ECG?
13 WHEN SIZE MATTERS! Arking et al performed a genome-wide association metaanalysis in 1,283 SCD cases and >20,000 control individuals tested the role of 49 SNPs previously implicated in modulating electrocardiographic traits (QRS, QT, and RR intervals). Consistent with epidemiological studies showing increased risk of SCD with prolonged QRS/QT intervals, the interval-prolonging alleles are in aggregate associated with increased risk for SCD (P=0.006).
14 ECG modifiers and SCD: more complexity PLN (QT/QRS, p = 0.013) NOS1AP (QT, p = 0.010) KCNQ1 (QT, p =0.014) TKT/CACNA1D/PRKCD (QRS, p = ) SURPRISINGLY HOWEVER In TKT/CACNA1D/PRKCD and the QRS/QT interval prolonging allele is associated with decreased risk for SCD.
15 From QRS prolongation to SCD It is clear that SNPs do not act individualluy to modify a complex trait. SNPs are COMMON but their EFFECT is SMALL More modifiers occur at the same time and they may have opposite effects A summation of the influence of different SPNs will have to be taken in consideration
16 Is the combination of LBB and dyssynchrony able to modulate the trascriptome?
17 What is remodeling? Cardiac myocytes are able to react to biomechanical stress caused by pressure or volume load, reactive oxygen species, cytokines, circulating neurohormones. Biomechanical stress activates signalling pathways converging on transcription factors, co-regulators mrna that alter gene expression and induce hypertrophy and dysfunction.
18 The Molecular Signature of HF Gene expression changes create a Molecular Signature for HF that includes among several other changes decreased expression of alpha-myosin heavy chain sarcoplasmic-endoplasmic reticulum (αmhc), calcium ATPase 2-a (SERCA2a), phospholamban (PLB) and increased expression of brain natriuretic peptide (BNP). Therapeutic interventions such as beta-blockers and ACE inhibitors reverse the remodeling associated with HF. IS THERE A REMODELING ASSOCIATED WITH DYSSYNCHRONY IN HF?
19 Increase in SERCA during CRT Twenty heart failure patients were evaluted before and after CRT. Biopsy samples were obtained to assess the effect of CRT on gene expression profile (CANDIDATE GENES). CRT was associated with a significant upregulation of SERCA2alpha P =.01), PLN (P =.01), their ratio (P =.01), ratio of SERCA/NCX (P =.02), beta1-ar (P =.03), and APL (P =.01) mrna levels. Mullens W Heart Rhythm 2008
20
21 Remodeling and CRT 24 Pts NYHA Class III and IV receiving CRT were divided into 2 groups according to their response to CRT. (Responders= increase in EF of 25% & NYHA class >1) LV mrna levels of α-mhc, β-mhc and BNP, SERCA, and PLN were analyzed. RESPONDERS SHOWED SIGNIFCANT NORMALIZATION OF EXPRESSION PROFILES Vanderheyden M et al JACC 2008
22
23 LBB and the trascriptome In a canine model of LBBB ( ablation) and pacing leading to HF it has been possible to demonstrate the change in the expression profile of 1050 transcripts. Energy-deriving processes, including oxidative phosphorylation, tricarboxylic acid cycle, fatty acid and amino acid metabolism, were concomitantly downregulated in failing myocardium, whereas various cell signaling pathways and extracellular matrix components were upregulated.
24 Figure 1. KEGG pathway analysis in tachycardia pacing-induced heart failure. Barth A S et al. Circ Cardiovasc Genet 2009;2:
25 Dyssynchrony increases heterogeneity in gene expression in the LV that is partially reduced by CRT. Barth A S et al. Circ Cardiovasc Genet 2009 Copyright American Heart Association
26 CONCLUSION 1: THE GENOME Genomic variants that influence QRS duration have also been associated with risk of SCD Some of them derive from GENES that cause Cardiac Conduction diseases, some others have been identified through GWAS studies HOWEVER interactions between SNPs has not been assessed carefully As far as the genetic basis of QRS in HF no studies have been conducted that allow to extrapolate findings obtained in the general population to HF patients.
27 CONCLUSION 2: THE TRANSCRIPTOME Animal studies showed that the PRE-SELECTION of genes that are likely to be differentially expressed provides a limited view on genetic remodeling. The same approach needs to be extended to human studies even if the inhertent difficultis make these studies complex. The major hurdle is represented by expression variations in genes that are still a functional mistery LOT OF WORK TO BE DONE BUT POTENTIALLY VERY REWARDING!
Genetics of Sudden Cardiac Death. Geoffrey Pitt Ion Channel Research Unit Duke University. Disclosures: Grant funding from Medtronic.
Genetics of Sudden Cardiac Death Geoffrey Pitt Ion Channel Research Unit Duke University Disclosures: Grant funding from Medtronic Duke U N I V E R S I T Y Sudden Cardiac Death High incidence 50-100 per
More informationGenetic testing in Cardiomyopathies
Genetic testing in Cardiomyopathies Silvia Giuliana Priori Cardiovascular Genetics, Langone Medical Center, New York University School of Medicine, New York, USA and Molecular Cardiology, IRCCS Fondazione
More informationCardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides
Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital
More informationDéclaration de Relations Professionnelles -Disclosure Statement of Financial Interest SPEAKER NAME. Nothing to disclose
Déclaration de Relations Professionnelles -Disclosure Statement of Financial Interest SPEAKER NAME Nothing to disclose Resynchronisation en pédiatrie Paediatric resynchronisation J. Janoušek Kardiocentrum
More informationIn Vivo Animal Models of Heart Disease. Why Animal Models of Disease? Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison
In Vivo Animal Models of Heart Disease Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison Why Animal Models of Disease? Heart Failure (HF) Leading cause of morbidity and mortality
More informationEffect of Ventricular Pacing on Myocardial Function. Inha University Hospital Sung-Hee Shin
Effect of Ventricular Pacing on Myocardial Function Inha University Hospital Sung-Hee Shin Contents 1. The effect of right ventricular apical pacing 2. Strategies for physiologically optimal ventricular
More informationFamilial DilatedCardiomyopathy Georgios K Efthimiadis, MD
Familial DilatedCardiomyopathy Georgios K Efthimiadis, MD Dilated Cardiomyopathy Dilated LV/RV, reduced EF, in the absence of CAD valvulopathy pericardial disease Prevalence:40/100.000 persons Natural
More informationStrength and weakness of genetic testing in clinical routine.
Strength and weakness of genetic testing in clinical routine. Silvia G Priori MD PhD Molecular Cardiology, IRCCS Fondazione Maugeri Pavia, Italy AND Leon Charney Division of Cardiology, Cardiovascular
More informationSilvia G Priori MD PhD
The approach to the cardiac arrest survivor Silvia G Priori MD PhD Molecular Cardiology, IRCCS Fondazione Salvatore Maugeri Pavia, Italy AND Leon Charney Division of Cardiology, Cardiovascular Genetics
More informationClinical Genetics in Cardiomyopathies
Clinical Genetics in Cardiomyopathies Γεώργιος Κ Ευθυμιάδης Αναπληρωτής Καθηγητής Καρδιολογίας ΑΠΘ No conflict of interest Genetic terms Proband: The first individual diagnosed in a family Mutation: A
More informationUpgrade to Resynchronization Therapy. Saeed Oraii MD, Cardiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic May 2016
Upgrade to Resynchronization Therapy Saeed Oraii MD, Cardiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic May 2016 Event Free Survival (%) CRT Cardiac resynchronization therapy (CRT)
More informationContribution of genetics for sudden death risk stratification in dilated cardiomyopathy
Contribution of genetics for sudden death risk stratification in dilated cardiomyopathy Pr Philippe Charron Centre de Référence pour les maladies cardiaques héréditaires (1) Hôpital Ambroise Paré, Boulogne
More informationHis Bundle Pacing in Bundle Branch Block May 11, 2017
His Bundle Pacing in Bundle Branch Block May 11, 2017 Gopi Dandamudi, MD FHRS System Medical Director, IUH Cardiac EP Program Director, IUH Atrial Fibrillation Center Assistant Professor of Clinical Medicine
More informationExercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart.
Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart. Hanne Rasmusen Consultant cardiologist, PhD Dept. of Cardiology Bispebjerg University Hospital
More informationArrhythmogenic Cardiomyopathy cases. Δέσποινα Παρχαρίδου Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογική κλινική ΑΧΕΠΑ
Arrhythmogenic Cardiomyopathy cases Δέσποινα Παρχαρίδου Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογική κλινική ΑΧΕΠΑ Definition ARVD (Arrhythmogenic Right Ventricular Dysplasia) Progressive loss of
More informationIndications for and Prediction of Successful Responses of CRT for Patients with Heart Failure
Indications for and Prediction of Successful Responses of CRT for Patients with Heart Failure Edmund Keung, MD Clinical Chief, Cardiology Section San Francisco VAMC October 25, 2008 Presentation Outline
More informationat least 4 8 hours per week
ECG IN ATHLETS An athlete is defined as an individual who engages in regular exercise or training for sport or general fitness, typically with a premium on performance, and often engaged in individual
More informationEHRA/EUROPACE 2011 Madrid, Spain June
EHRA/EUROPACE 2011 Madrid, Spain June 26.-29.2011 Implementing modern management in atrial fibrillation patients Proceedings from the 3rd AFNet/EHRA consensus conference EHRA Special Session Different
More informationComparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure
HOT TOPIC Cardiology Journal 2010, Vol. 17, No. 6, pp. 543 548 Copyright 2010 Via Medica ISSN 1897 5593 Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart
More informationCardiac Resynchronization Therapy for Heart Failure
Cardiac Resynchronization Therapy for Heart Failure Ventricular Dyssynchrony vs Resynchronization Ventricular Dysynchrony Ventricular Dysynchrony 1 Electrical: Inter- or Intraventricular conduction delays
More informationRisk prediction in inherited conditions Laminopathies
Risk prediction in inherited conditions Laminopathies Karim Wahbi Cochin hospital, Paris karim.wahbi@aphp.fr Risk prediction in laminopathies Current approach for risk stratification A new score to predict
More informationImportance of CRT team for optimization of the results: a European point of view
Importance of CRT team for optimization of the results: a European point of view Matteo Bertini, MD, PhD Arcispedale S. Anna Azienda Ospedaliero-Universitaria Cona-Ferrara No conflict of interest to declare
More informationInterventional solutions for atrial fibrillation in patients with heart failure
Interventional solutions for atrial fibrillation in patients with heart failure Advances in Cardiovascular Arrhythmias Great Innovations in Cardiology Matteo Anselmino, MD PhD Division of Cardiology Department
More informationDialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy
Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS
More informationFrom left bundle branch block to cardiac failure
OF JOURNAL HYPERTENSION JH R RESEARCH Journal of HYPERTENSION RESEARCH www.hypertens.org/jhr Original Article J Hypertens Res (2017) 3(3):90 97 From left bundle branch block to cardiac failure Cătălina
More informationIt has been shown from meta-analysis of randomized clinical trials that patients with a pre-crt QRS duration (QRSD) >150 ms benefit
Cardiac Resynchronization Therapy may be detrimental in patients with a Very Wide QRSD > 180 ms (VWQRSD) and Right Bundle Branch Block Morphology: Analysis From the Medicare ICD Registry Varun Sundaram
More informationCardiac resynchronisation therapy (biventricular pacing) for the treatment of heart failure
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal for the treatment of heart failure Final scope Appraisal objective To appraise the clinical and cost effectiveness of cardiac
More informationLES NOUVEAUX TROUBLES DE CONDUCTION HEREDITAIRES
LES NOUVEAUX TROUBLES DE CONDUCTION HEREDITAIRES Alban Baruteau L institut du thorax, INSERM 1087 CNRS 6291 IRS Université de Nantes Centre Chirurgical Marie Lannelongue M3C Université Paris Sud Le Kremlin
More informationA CRITICAL MANIFESTATION OF HYPOTHYROIDISM W.S.R. TO ECG INDIFFERENT DEHAPRAKRITI
INTERNATIONAL AYURVEDIC MEDICAL JOURNAL International Ayurvedic Medical Journal, (ISSN: 2320 5091) (March, 2017) 5 (3) A CRITICAL MANIFESTATION OF HYPOTHYROIDISM W.S.R. TO ECG INDIFFERENT DEHAPRAKRITI
More informationUpdate in Cardiomyopathies: Their New Classifications and Importance of Mixed Phenotypes
Update in Cardiomyopathies: Their New Classifications and Importance of Mixed Phenotypes Andre Keren MD Hadassah-Hebrew University Hospital, Jerusalem Cesarea, 2008 f o s r a es e y t hi 0 a 5 p t o rs
More informationSEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !
Sudden cardiac death in the adult Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel.! " # $ % Cancers National Vital Statistics Report, Vol 49 (11), Oct. 12, 2001. 20% 25% State-specific
More information1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and
1 The clinical syndrome of heart failure in adults is commonly associated with the etiologies of ischemic and non-ischemic dilated cardiomyopathy, hypertrophic cardiomyopathy, hypertensive heart disease,
More informationWhat s new in heart failure management? Yonsei Cardiovascular Center Yonsei University College of Medicine
What s new in heart failure management? Yonsei Cardiovascular Center Yonsei University College of Medicine Current Guideline of Treatment Asymptomatic Mild/Mod Severe Refractory Correct Cause: Arrhythmias
More informationVentricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC
Ventricular Tachycardia Ablation Saverio Iacopino, MD, FACC, FESC ü Ventricular arrhythmias, both symptomatic and asymptomatic, are common, but syncope and SCD are infrequent initial manifestations of
More informationCardiac Considerations and Care in Children with Neuromuscular Disorders
Cardiac Considerations and Care in Children with Neuromuscular Disorders - importance of early and ongoing treatment, management and available able medications. Dr Bo Remenyi Department of Cardiology The
More informationA rare variant in MYH6 confers high risk of sick sinus syndrome. Hilma Hólm ESC Congress 2011 Paris, France
A rare variant in MYH6 confers high risk of sick sinus syndrome Hilma Hólm ESC Congress 2011 Paris, France Disclosures I am an employee of decode genetics, Reykjavik, Iceland. Sick sinus syndrome SSS is
More informationInherited Arrhythmia Syndromes
Inherited Arrhythmia Syndromes When to perform Genetic testing? Arthur AM Wilde February 4, 2017 Which pts should undergo genetic testing? SCD victims with a likely diagnosis Pts diagnosed with an inherited
More informationDIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY. David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong
APHRS Summit 2018 in conjunction with HKCC Heart Rhythm Refresher Course DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong
More informationLEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR?
LEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR? Juan Cinca Department and Chair of Cardiology Hospital de la Santa Creu i Sant Pau Universitat Autònoma de Barcelona
More informationElectrocardiographic abnormalities in patients with pulmonary sarcoidosis (RCD code: III)
Journal of Rare Cardiovascular Diseases 2017; 3 (3): 81 85 www.jrcd.eu ORIGINAL PAPER Diseases of the heart Electrocardiographic abnormalities in patients with pulmonary sarcoidosis (RCD code: III) Justyna
More informationDysrhythmias. Dysrythmias & Anti-Dysrhythmics. EKG Parameters. Dysrhythmias. Components of an ECG Wave. Dysrhythmias
Dysrhythmias Dysrythmias & Anti-Dysrhythmics Rhythm bad in the heart: Whitewater rafting Electrical impulses coordinate heart Reduction in Cardiac Output PEA Asystole Components of an ECG Wave EKG Parameters
More informationName of Presenter: Marwan Refaat, MD
NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010 I have no actual or potential conflict of interest in relation
More informationThe Approach to Patients with Heart Failure and Mid-Range (40-50%) Ejection Fraction (HFmrEF)
The Approach to Patients with Heart Failure and Mid-Range (40-50%) Ejection Fraction (HFmrEF) 22 nd Annual Heart Failure 2018 an Update on Therapy April 21, 2018 Los Angeles, CA Barry Greenberg, M.D. Distinguished
More informationIndex of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125
145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency
More informationHypertrophic Cardiomyopathy: Patient Management in 2018
Hypertrophic Cardiomyopathy: Patient Management in 2018 Mackram F. Eleid, MD Giornate Cardiologeche Torinesi October 26, 2018 2018 MFMER slide-1 Disclosures No relevant financial relationships to disclose
More informationBreed specificities of Canine Dilated Cardiomyopathy Dr. Gerhard Wess
Breed specificities of Canine Dilated Cardiomyopathy Dr. Gerhard Wess Diplomate ACVIM (Cardiology) Diplomate ECVIM-CA (Cardiology) Diplomate ECVIM-CA (Internal Medicine) INTRODUCTION Inherent disease of
More informationGender and cardiac resynchronization therapy. Chairs: David Heaven & Belinda Green. Gender and Cardiac Resynchronisation Therapy
Electrophysiology Gender and cardiac resynchronization therapy Dean Boddington Chairs: David Heaven & Belinda Green Gender and Cardiac Resynchronisation Therapy Dean Boddington Tauranga Hospital 1 Disclosure/Warning
More informationCRT in the RV Paced Patient When to Upgrade?
Ben Gurion University CRT in the RV Paced Patient When to Upgrade? I. Eli Ovsyshcher, MD, PhD, FESC, FACC, FHRS, FA Professor of Medicine/Cardiology Ben Gurion University of the Negev Beer-Sheva, Israel
More information8/8/2011. CARDIAC RESYCHRONIZATION THERAPY for Heart Failure. Case Presentation. Case Presentation
CARDIAC RESYCHRONIZATION THERAPY for Heart Failure James Taylor, DO, FACOS Cardiothoracic and Vascular surgery San Angelo Community Medical Center San Angelo, TX Case Presentation 64 year old female with
More informationHypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy From Genetics to ECHO Alexandra A Frogoudaki Second Cardiology Department ATTIKON University Hospital Athens University Athens, Greece EUROECHO 2010, Copenhagen, 11/12/2010
More informationThe Genetics and Prevention of Sudden Cardiac Death
The Genetics and Prevention of Sudden Cardiac Death Sudden cardiac death (SCD), a serious public health problem Every day, between 1,600 and 2,000 people die worldwide from genetically caused SCD. 1 SCD
More informationImaging in dilated cardiomyopathy : factors associated with a poor outcome
Imaging in dilated cardiomyopathy : factors associated with a poor outcome Johan De Sutter, MD, PhD, FESC AZ Maria Middelares Gent and University Gent - Belgium Dilated cardiomyopathy Cardiomyopathy with
More informationΠρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια:
Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια: Νεώτερα δεδομένα στη διαστρωμάτωση κινδύνου Εμμ. Μ. Κανουπάκης MD, PhD, FESC Πανεπιστημιακό Νοσοκομείο Ηρακλείου NIDCM Presence of LV dilatation
More informationDiploma in Electrocardiography
The Society for Cardiological Science and Technology Diploma in Electrocardiography The Society makes this award to candidates who can demonstrate the ability to accurately record a resting 12-lead electrocardiogram
More informationHow to Approach the Patient with CRT and Recurrent Heart Failure
How to Approach the Patient with CRT and Recurrent Heart Failure Byron K. Lee MD Associate Professor of Medicine Electrophysiology and Arrhythmia Section UCSF Update in Electrocardiography and Arrhythmias
More informationA Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE
A Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE Adele Greyling Dora Nginza Hospital, Port Elizabeth SA Heart November 2017 What are the guidelines based on? MADIT-II Size:
More informationCardiac Resynchronization Therapy Guidelines and Missing Groups
Cardiac Resynchronization Therapy Guidelines and Missing Groups Frank Pelosi, Jr., MD, FACC, FHRS Director, Cardiac Electrophysiology Fellowship Associate Professor of Medicine University of Michigan Health
More informationC. Lutman, L. Vitali Serdoz, G. Barbati, E. Cadamuro, S. Magnani, M. Zecchin, M. Merlo, G. Sinagra
C. Lutman, L. Vitali Serdoz, G. Barbati, E. Cadamuro, S. Magnani, M. Zecchin, M. Merlo, G. Sinagra Cardiovascular Department, Ospedali Riuniti and University, Trieste, Italy PURPOSE Sex differences exist
More informationHeart Failure Overview. Dr Chris K Y Wong
Heart Failure Overview Dr Chris K Y Wong Heart Failure: A Growing, Global Health Issue Heart Failure 23 Million Afflicted Global Impact Worldwide ~23 million peopleworldwide afflicted with CHF 1 Exceeds
More informationRisk Stratification in Heart Failure: The Role of Emerging Biomarkers
Risk Stratification in Heart Failure: The Role of Emerging Biomarkers David G. Grenache, PhD Associate Professor of Pathology, University of Utah Medical Director, ARUP Laboratories Salt Lake City, UT
More informationDeclaration of conflict of interest
Declaration of conflict of interest Electrical activation pattern in Left Bundle Branch Block Patients Angelo Auricchio, MD FESC Director, Cardiac Electrophysiology Programme, Fondazione Cardiocentro Ticino,
More informationAntony French Consultant Cardiologist & Electrophysiologist
Antony French Consultant Cardiologist & Electrophysiologist Palpitations Unpleasant awareness of rapid or forceful heart beat Not all tachycardias cause palpitations, and not all palpitations are due to
More informationΜΥΟΚΑΡΔΙΟΠΑΘΕΙΕΣ. Ανεξήγητη βραδυκαρδία µε ή χωρίς διαταραχές κολποκοιλιακής αγωγής: τι µπορεί να κρύβει? ΕΦΗ Ι. ΠΡΑΠΠΑ Καρδιολόγος
ΜΥΟΚΑΡΔΙΟΠΑΘΕΙΕΣ Ανεξήγητη βραδυκαρδία µε ή χωρίς διαταραχές κολποκοιλιακής αγωγής: τι µπορεί να κρύβει? ΕΦΗ Ι. ΠΡΑΠΠΑ Καρδιολόγος Β Καρδιολογική Κλινική, ΠΓΝΑ «Ο ΕΥΑΓΓΕΛΙΣΜΟΣ» CONFLICT of INTEREST : none
More informationECG Underwriting Puzzler Dr. Regina Rosace AVP & Medical Director
December 2018 ECG Underwriting Puzzler Dr. Regina Rosace AVP & Medical Director To obtain best results Select Slide Show from the ribbon at the top of your PowerPoint screen Select From Beginning on the
More informationFamily Medicine for English language students of Medical University of Lodz ECG. Jakub Dorożyński
Family Medicine for English language students of Medical University of Lodz ECG Jakub Dorożyński Parts of an ECG The standard ECG has 12 leads: six of them are considered limb leads because they are placed
More informationCKD Satellite Symposium
CKD Satellite Symposium Recommended Therapy by Heart Failure Stage AHA/ACC Task Force on Practice Guideline 2001 Natural History of Heart Failure Patients surviving % Mechanism of death Sudden death 40%
More informationBENEFIT OF CRT IN MILDLY SYMPTOMATIC HEART FAILURE RECENT DATA FROM MADIT-CRT AND RAFT
BENEFIT OF CRT IN MILDLY SYMPTOMATIC HEART FAILURE RECENT DATA FROM MADIT-CRT AND RAFT Ilan Goldenberg MD Professor of Cardiology Sheba Medical Center and Tel Aviv University, Israel University of Rochester
More informationNoninvasive Predictors of Sudden Cardiac Death
2011 년순환기관련학회춘계통합학술대회 Noninvasive Predictors of Sudden Cardiac Death 영남대학교의과대학순환기내과학교실신동구 Diseases associated with SCD Previous SCD event Prior episode of ventricular tachyarrhythmia Previous myocardial
More informationChapter 2 Practical Approach
Chapter 2 Practical Approach There are beginners in electrocardiogram (ECG) analysis who are fascinated by a special pattern (e.g., a bundle-branch block or a striking Q wave) and thereby overlook other
More informationTRATTAMENTO INTERVENTISTICO. Dr. Antonio Sagone
TRATTAMENTO INTERVENTISTICO Dr. Antonio Sagone 1 Heart Failure Prevalence & Prognosis Over 26 million people worldwide suffer from heart failure, a chronic, progressive condition in which the heart muscle
More informationGenetics of Atrial Fibrillation: does it help in treatment decisions?
Genetics of Atrial Fibrillation: does it help in treatment decisions? Atrial fibrillation Pathophysiology of atrial fibrillation (AF) Genetic loci identified for AF Role in therapy outcome ardiologie Molecular
More informationHereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases
Hereditary Cardiovascular Conditions genetic testing for undiagnosed diseases What is Hypertrophic Cardiomyopathy (HCM)? normal heart heart with hcm Extra or thick heart muscle Typically in the left ventricle
More informationImpact of QRS duration and morphology on CRT effectiveness
Impact of QRS duration and morphology on CRT effectiveness Dr Tim Betts MD MBChB FRCP Consultant Cardiologist & Electrophysiologist Oxford Heart Centre, John Radcliffe Hospital Oxford University Hospitals
More informationTachycardia-induced heart failure - Does it exist?
Tachycardia-induced heart failure - Does it exist? PD Dr Etienne Delacrétaz Clinique Cecil et Hôpital de Fribourg SSC Cardiology meeting 2015 Zürich Rapid atrial fibrillation is a common cause of heart
More informationEarlier studies, mainly in rodents, have shown that diabetic
Downregulation of Myocardial Myocyte Enhancer Factor 2C and Myocyte Enhancer Factor 2C Regulated Gene Expression in Diabetic Patients With Nonischemic Heart Failure Peter Razeghi, MD; Martin E. Young,
More informationin Familial Dilated Cardiomyopathy
Familial Dilated Cardiomyopathy y Clinical and Genetic et Issues in Familial Dilated Cardiomyopathy College of Medicine, Chungbuk National University Kyung-Kuk Hwang Contents Definition (criteria) Clinical
More informationCardiac Gene Therapy: Beyond the Mouse. David M Kaye Heart Failure Research Group Baker IDI, Melbourne, AUSTRALIA
Cardiac Gene Therapy: Beyond the Mouse David M Kaye Heart Failure Research Group Baker IDI, Melbourne, AUSTRALIA Presenter Disclosure Information FINANCIAL DISCLOSURE: Equity: Osprey Medical Grants/Research
More informationCardiomyopathy in Fabry s disease
Cardiomyopathy in Fabry s disease Herzinsuffizienzlunch Basel, 11.09.2018 Christiane Gruner Kardiologie, UniversitätsSpital Zürich Content Background / epidemiology Differential diagnosis Clinical presentations
More informationPearls of the ESC/ERS Guidelines 2015 Channelopathies
Pearls of the ESC/ERS Guidelines 2015 Channelopathies Carina Blomstrom Lundqvist Dept Cardiology, Uppsala, Sweden Content 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias
More informationTachycardia Devices Indications and Basic Trouble Shooting
Tachycardia Devices Indications and Basic Trouble Shooting Peter A. Brady, MD., FRCP Cardiology Review Course London, March 6 th, 2014 2011 MFMER 3134946-1 Tachycardia Devices ICD Indications Primary and
More informationECG interpretation basics
ECG interpretation basics Michał Walczewski, MD Krzysztof Ozierański, MD 21.03.18 Electrical conduction system of the heart Limb leads Precordial leads 21.03.18 Precordial leads Precordial leads 21.03.18
More informationSolutions for Every Day Problems Cardiologists and the ECG: Are We Really That Good at It? Part II Daniel José Piñeiro Profesor Titular de Medicina,
Solutions for Every Day Problems Cardiologists and the ECG: Are We Really That Good at It? Part II Daniel José Piñeiro Profesor Titular de Medicina, Universidad de Buenos Aires, Argentina Member, Membership
More informationBiomarkers in cardiovascular disease. Felix J. Rogers, DO, FACOI April 29, 2018
Biomarkers in cardiovascular disease Felix J. Rogers, DO, FACOI April 29, 2018 Biomarkers NIH: A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biological
More informationCorporate Medical Policy
Corporate Medical Policy Genetic Testing for Predisposition to Inherited Hypertrophic File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_predisposition_to_inherited_hypertrophic_cardiomyopathy
More informationCardiac Resynchronization ICD Therapy: What is New?
Cardiac Resynchronization ICD Therapy: What is New? Emile Daoud, MD Section Chief, Cardiac Electrophysiology Professor of Medicine The Ohio State University Normal Activation, Narrow QRS Synchrony Abnormal
More informationFrom Bench to Practice: Cardiac Resynchronisation Therapy
From Bench to Practice: Cardiac Resynchronisation Therapy Molecular Changes in the Dyssynchronous Heart and Cardiac Resynchronisation Therapy Gordon F. Tomaselli, M.D. Professor of Medicine and Molecular
More informationSudden cardiac death (SCD) accounts for 20% of mortality. Sudden Cardiac Death Compendium. Genetics of Sudden Cardiac Death
Sudden Cardiac Death Compendium Circulation Research Compendium on Sudden Cardiac Death The Spectrum of Epidemiology Underlying Sudden Cardiac Death Sudden Cardiac Death Risk Stratification Genetics of
More informationLeft ventricular non-compaction: the New Cardiomyopathy on the Block
Left ventricular non-compaction: the New Cardiomyopathy on the Block Aamir Jeewa MB BCh, FAAP, FRCPC Section Head, Cardiomyopathy & Heart Function Program The Hospital for Sick Children Assistant Professor
More informationC. Quarta, L. Obici, S. Longhi, S. Perlini, A. Milandri, F. Del Corso, F. Perfetto, F. Cappelli, G. Merlini, C. Rapezzi
Hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: disease profile and differential diagnosis with hypertrophic cardiomyopathy and senile systemic amyloidosis C. Quarta, L.
More informationDefinition and classification of the cardiomyopathies. Georgios K Efthimiadis Ass Prof of Cardiology
Definition and classification of the cardiomyopathies Georgios K Efthimiadis Ass Prof of Cardiology Historical Context WHO: 1980 classification "heart muscle diseases of unknown cause" WHO 1995 classification
More informationCardiomyopathy. ACOI IM Board Review 2018 Martin C. Burke DO, FACOI
Cardiomyopathy ACOI IM Board Review 2018 Martin C. Burke DO, FACOI No Disclosures Cardiomyopathies Definition: diseases of heart muscle 1980 WHO: unknown causes Not clinically relevant 1995 WHO: diseases
More information1. Cardiomyocytes and nonmyocyte. 2. Extracellular Matrix 3. Vessels שאלה 1. Pathobiology of Heart Failure Molecular and Cellular Mechanism
Pathobiology of Heart Failure Molecular and Cellular Mechanism Jonathan Leor Neufeld Cardiac Research Institute Tel-Aviv University Sheba Medical Center, Tel-Hashomer שאלה 1 התא הנפוץ ביותר (75%~) בלב
More informationSilvia G Priori MD PhD
Novel therapies for the long QT syndrome. Silvia G Priori MD PhD Molecular Cardiology, IRCCS Fondazione Salvatore Maugeri Pavia, Italy and Leon Charney Division of Cardiology, Cardiovascular Genetics Program,
More informationGene annotation for heart rhythm. 1. Control of heart rate 2. Action Potential 3. Ion channels and transporters 4. Arrhythmia 5.
Gene annotation for heart rhythm 1. Control of heart rate 2. Action Potential 3. Ion channels and transporters 4. Arrhythmia 5. EC coupling Control of heart rate Autonomic regulation of heart function
More informationHis Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017
His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017 Conflicts Medtronic: Research, Honoraria, Consulting Boston Scientific: Research,
More informationElectrical System Overview Electrocardiograms Action Potentials 12-Lead Positioning Values To Memorize Calculating Rates
Electrocardiograms Electrical System Overview James Lamberg 2/ 74 Action Potentials 12-Lead Positioning 3/ 74 4/ 74 Values To Memorize Inherent Rates SA: 60 to 100 AV: 40 to 60 Ventricles: 20 to 40 Normal
More informationThis is What I do to Improve CRT Response for CRT Non-Responders
This is What I do to Improve CRT Response for CRT Non-Responders Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Steering Committees (unpaid) and Clinical Trials,
More informationAppendix D Output Code and Interpretation of Analysis
Appendix D Output Code and Interpretation of Analysis 8 Arrhythmia Code No. Description 8002 Marked rhythm irregularity 8110 Sinus rhythm 8102 Sinus arrhythmia 8108 Marked sinus arrhythmia 8120 Sinus tachycardia
More informationIncidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation
Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Ömer Aktug 1, MD; Guido Dohmen 2, MD; Kathrin Brehmer 1, MD; Verena Deserno 1 ; Ralf Herpertz 1 ; Rüdiger
More informationSteel vs Alcohol. Or Neither. Management of Hypertrophic Cardiomyopathy. Josh Doll, MD January 24, 2015
Steel vs Alcohol Or Neither Management of Hypertrophic Cardiomyopathy Josh Doll, MD January 24, 2015 47yo Male, Mr. L Severe progressive dyspnea on exertion and weight gain Previous avid Cross-Fit participant
More information